• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It.奥沙利铂相关性门静脉海绵样变:一种需要考虑的疾病实体。
Cells. 2019 Nov 24;8(12):1506. doi: 10.3390/cells8121506.
2
Oxaliplatin-related Portal Hypertension Complicated with Esophageal Varices and Refractory Massive Ascites.奥沙利铂相关性门静脉高压症并发食管静脉曲张和难治性大量腹水。
Intern Med. 2022 Nov 1;61(21):3225-3231. doi: 10.2169/internalmedicine.9266-21. Epub 2022 Apr 2.
3
Endoscopic treatment of gastroesophageal variceal bleeding after oxaliplatin-based chemotherapy in patients with colorectal cancer.结直肠肿瘤患者奥沙利铂化疗后胃食管静脉曲张出血的内镜治疗。
Endoscopy. 2020 Sep;52(9):727-735. doi: 10.1055/a-1157-8611. Epub 2020 May 7.
4
Ectopic variceal bleeding secondary to porto-sinusoidal vascular disease.肝窦前性门静脉高压症导致的异位静脉曲张出血。
Rev Esp Enferm Dig. 2024 May;116(5):287-288. doi: 10.17235/reed.2023.9683/2023.
5
Isolated gastric variceal bleeding related to non-cirrhotic portal hypertension following oxaliplatin-based chemotherapy: A case report.奥沙利铂为基础的化疗后继发非肝硬化性门静脉高压孤立性胃静脉曲张出血 1 例报告
World J Gastroenterol. 2022 Jul 21;28(27):3524-3531. doi: 10.3748/wjg.v28.i27.3524.
6
Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury.与奥沙利铂给药相关的门静脉高压:肝窦损伤的临床表现
Clin Colorectal Cancer. 2009 Oct;8(4):225-30. doi: 10.3816/CCC.2009.n.038.
7
Hepatic hemodynamics in 24 patients with nodular regenerative hyperplasia and symptomatic portal hypertension.24 例结节性再生性增生和症状性门脉高压患者的肝血流动力学。
J Gastroenterol Hepatol. 2012 Aug;27(8):1336-40. doi: 10.1111/j.1440-1746.2012.07168.x.
8
[Non-cirrhotic portal hypertension - The point of view of the pathologis].非肝硬化性门静脉高压症——病理学家的观点
Ther Umsch. 2019;76(7):359-363. doi: 10.1024/0040-5930/a001106.
9
[A case of portal hypertension after the treatment of oxaliplatin based adjuvant chemotherapy for rectal cancer].[1例直肠癌奥沙利铂辅助化疗后发生门静脉高压的病例]
Korean J Gastroenterol. 2011 Apr;57(4):253-7. doi: 10.4166/kjg.2011.57.4.253.
10
[Porto sinusoidal vascular disease: an unusual cause of digestive bleeding].[门静脉窦状隙血管疾病:消化性出血的一种罕见病因]
Rev Gastroenterol Peru. 2024 Apr-Jun;44(2):145-149.

引用本文的文献

1
Portal Vein Thrombosis in Patients Without Cirrhosis: Current Practical Approaches and Treatment Strategies.非肝硬化患者的门静脉血栓形成:当前实用方法与治疗策略
Diagnostics (Basel). 2025 Mar 13;15(6):721. doi: 10.3390/diagnostics15060721.
2
Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management.非肝硬化性门脉纤维化/特发性门脉高压:亚太肝脏研究学会诊断与管理推荐意见
Hepatol Int. 2024 Dec;18(6):1684-1711. doi: 10.1007/s12072-024-10739-6. Epub 2024 Nov 15.
3
Diagnosis and treatment of bacterial peritonitis in patients with gastrointestinal cancer: an observational multicenter study.胃肠道癌患者细菌性腹膜炎的诊断与治疗:一项多中心观察性研究
Ther Adv Med Oncol. 2024 Jun 5;16:17588359241258440. doi: 10.1177/17588359241258440. eCollection 2024.
4
Case report: Oxaliplatin-induced idiopathic non-cirrhotic portal hypertension: a case report and literature review.病例报告:奥沙利铂诱导的特发性非肝硬化门静脉高压症:一例病例报告及文献综述
Front Med (Lausanne). 2023 Nov 28;10:1285064. doi: 10.3389/fmed.2023.1285064. eCollection 2023.
5
Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis.血管性肝脏疾病的分子机制:聚焦于血栓形成。
Int J Mol Sci. 2023 Aug 13;24(16):12754. doi: 10.3390/ijms241612754.
6
Impact of neoadjuvant chemotherapy on the difficulty and outcomes of laparoscopic and robotic major liver resections for colorectal liver metastases: A propensity-score and coarsened exact-matched controlled study.新辅助化疗对腹腔镜和机器人结直肠癌肝转移根治性肝切除难度和结局的影响:倾向评分和粗糙精确匹配对照研究。
Eur J Surg Oncol. 2023 Jul;49(7):1209-1216. doi: 10.1016/j.ejso.2023.01.014. Epub 2023 Jan 20.
7
Splenomegaly during oxaliplatin-based chemotherapy: impact on blood parameters and anti-neoplastic treatment.基于奥沙利铂的化疗期间脾肿大:对血液参数和抗肿瘤治疗的影响
Transl Cancer Res. 2022 Jul;11(7):1880-1888. doi: 10.21037/tcr-22-83.
8
Model establishment and microarray analysis of mice with oxaliplatin‑induced hepatic sinusoidal obstruction syndrome.建立奥沙利铂诱导的肝窦阻塞综合征小鼠模型并进行基因芯片分析。
Mol Med Rep. 2022 Nov;26(5). doi: 10.3892/mmr.2022.12862. Epub 2022 Sep 30.
9
Comparison Between Liver Stiffness Measurement by Fibroscan and Splenic Volume Index as NonInvasive Tools for the Early Detection of Oxaliplatin-induced Hepatotoxicity.Fibroscan测量肝脏硬度与脾体积指数作为早期检测奥沙利铂诱导肝毒性的非侵入性工具的比较
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):448-453. doi: 10.1016/j.jceh.2021.06.007. Epub 2021 Jun 15.
10
Oxaliplatin-related Portal Hypertension Complicated with Esophageal Varices and Refractory Massive Ascites.奥沙利铂相关性门静脉高压症并发食管静脉曲张和难治性大量腹水。
Intern Med. 2022 Nov 1;61(21):3225-3231. doi: 10.2169/internalmedicine.9266-21. Epub 2022 Apr 2.

本文引用的文献

1
Incidence of portal hypertension in patients exposed to oxaliplatin.接受奥沙利铂治疗的患者门静脉高压症的发病率。
Dig Liver Dis. 2019 Sep;51(9):1348-1350. doi: 10.1016/j.dld.2019.06.020. Epub 2019 Jul 15.
2
Portal Pressure in Noncirrhotic Portal Hypertension: To Measure or Not to Measure.非肝硬化性门静脉高压症的门静脉压力:测还是不测
Hepatology. 2019 Dec;70(6):2228-2230. doi: 10.1002/hep.30862. Epub 2019 Oct 9.
3
Oxaliplatin-Based Regimen is Superior to Cisplatin-Based Regimen in Tumour Remission as First-line Chemotherapy for Advanced Gastric Cancer: A Meta-Analysis.奥沙利铂方案作为晚期胃癌一线化疗在肿瘤缓解方面优于顺铂方案:一项荟萃分析
J Cancer. 2019 Apr 25;10(8):1923-1929. doi: 10.7150/jca.28896. eCollection 2019.
4
Porto-sinusoidal vascular disease: proposal and description of a novel entity.窦周隙血管病:一种新实体的提出与描述。
Lancet Gastroenterol Hepatol. 2019 May;4(5):399-411. doi: 10.1016/S2468-1253(19)30047-0.
5
Idiopathic Portal Hypertension.特发性门静脉高压症。
Hepatology. 2018 Dec;68(6):2413-2423. doi: 10.1002/hep.30132.
6
The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia.贝伐珠单抗联合奥沙利铂化疗对肝窦内皮损伤和血小板减少的影响。
J Natl Cancer Inst. 2018 Aug 1;110(8):888-894. doi: 10.1093/jnci/djx288.
7
Liver transplantation in adults with liver disease due to common variable immunodeficiency leads to early recurrent disease and poor outcome.成人因普通可变免疫缺陷导致的肝病行肝移植后会早期复发疾病且预后不良。
Liver Transpl. 2018 Feb;24(2):171-181. doi: 10.1002/lt.24979.
8
Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN).化疗诱导的周围神经病变(CIPN)中的线粒体功能障碍
Toxics. 2015 Jun 5;3(2):198-223. doi: 10.3390/toxics3020198.
9
Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.肝脏血管疾病。加泰罗尼亚消化病学会和西班牙肝脏研究协会临床指南。
Gastroenterol Hepatol. 2017 Oct;40(8):538-580. doi: 10.1016/j.gastrohep.2017.03.011. Epub 2017 Jun 11.
10
Prevalence of histological features of idiopathic noncirrhotic portal hypertension in general population: a retrospective study of incidental liver biopsies.一般人群中特发性非肝硬化性门静脉高压的组织学特征的流行情况:偶然肝活检的回顾性研究。
Hepatol Int. 2017 Sep;11(5):452-460. doi: 10.1007/s12072-017-9801-6. Epub 2017 Jun 8.

奥沙利铂相关性门静脉海绵样变:一种需要考虑的疾病实体。

Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It.

机构信息

Digestive Disease Department, Marqués de Valdecilla University Hospital, Cantabria University, Av. Valdecilla s/n, 39008 Santander, Spain.

Health Research Institute Marques de Valdeciila, IDIVAL, 39011 Santander, Spain.

出版信息

Cells. 2019 Nov 24;8(12):1506. doi: 10.3390/cells8121506.

DOI:10.3390/cells8121506
PMID:31771307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6952805/
Abstract

Portal sinusoidal vascular disease is a presinusoidal cause of portal hypertension (PHT) of unknown etiology, characterized by typical manifestations of PHT (esophageal varices, ascites, portosystemic collaterals), plaquetopenia and splenomegaly with a gradient of portal pressure slightly increased, according to the presinusoidal nature of the PHT. A few cases in the literature have shown a relationship between oxaliplatin and the development of presinusoidal portal hypertension, years after the chemotherapy for colorectal cancer (therefore, different to sinusoidal obstruction syndrome). There are three mechanisms through which oxaliplatin can cause sinusoidal damage: 1) damage at the level of endothelial cells and stimulates the release of free radicals and depletion of glutathione transferase, with altering the integrity of the sinusoidal cells. The damage in the endothelial sinusoidal cells allows to erythrocytes to across into the Dissé space and formation of perisinusoidal fibrosis, 2) the appearance of nodular regenerative hyperplasia is favored by the chronic hypoxia of the centrilobular areas and, finally, 3) oxaliplatin can generate an obliteration of the blood capillaries and zones of parenchymal extinction. These three facts can develop, in a minority of cases, the appearance of a presinusoidal increase of portal pressure, which typically appears years after the completion of chemotherapy and sometimes is underdiagnosed until variceal bleeding, ascites or encephalopathy appear. The knowledge of this pathology is essential to be able to perform an early diagnostic and consult to the hepatologist

摘要

窦周静脉血管病是一种未知病因的门静脉高压(PHT)的前窦性原因,其特征为典型的 PHT 表现(食管静脉曲张、腹水、门体侧支循环)、血小板减少和脾肿大,门静脉压力梯度略有增加,根据 PHT 的前窦性性质。文献中有少数几例显示奥沙利铂与前窦性门静脉高压的发展之间存在关系,即在结直肠癌的化疗多年后(因此,与窦状阻塞综合征不同)。奥沙利铂可通过三种机制引起窦状损伤:1)损伤内皮细胞水平并刺激自由基释放和谷胱甘肽转移酶耗竭,改变窦状细胞的完整性。内皮窦状细胞的损伤使红细胞穿过 Disse 间隙并形成窦周纤维化,2)结节性再生性增生的出现有利于中心区的慢性缺氧,最后,3)奥沙利铂可导致毛细血管闭塞和实质消失区。在少数情况下,这三个因素会导致门静脉压力的前窦性升高,这种情况通常在化疗完成后数年出现,有时直到出现静脉曲张出血、腹水或肝性脑病才被诊断出来。了解这种病理学对于能够进行早期诊断并咨询肝病学家至关重要。